A3650
アミカシン 水和物
aminoglycoside antibiotic
別名:
N1-[(S)-4-アミノ-2-ヒドロキシブチリル]カナマイシンA
ログインで組織・契約価格をご覧ください。
サイズを選択してください
表示を変更する
この商品について
実験式（ヒル表記法）:
C22H43N5O13 · xH2O
CAS番号:
分子量:
585.60 (anhydrous basis)
UNSPSC Code:
51281632
NACRES:
NA.85
PubChem Substance ID:
EC Number:
253-538-5
Beilstein/REAXYS Number:
1445422
MDL number:
biological source
synthetic
Quality Level
form
powder
color
white to almost white
antibiotic activity spectrum
Gram-negative bacteria, mycobacteria
mode of action
protein synthesis | interferes
storage temp.
2-8°C
SMILES string
O.NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O
InChI
1S/C22H43N5O13.H2O/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);1H2/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;/m0./s1
InChI key
DTSOZYYWEZJFSS-XTHCGPPUSA-N
General description
化学構造：アミノグリコシド
Application
アミカシン水和物はMycobacterium tuberculosis（結核菌）やEhrlichia phagocytophilaなどの抗菌剤感受性の研究に用いられます。
Biochem/physiol Actions
アミカシンは細菌の30Sリボソームサブユニットに結合しmRNAの読み誤りを誘発することでタンパク質合成を阻害します。tRNAのAサイトからPサイトへの転座を妨害します。
Packaging
5G
Other Notes
容器は固く閉め、乾燥した、通気の良い場所で保管してください。
保管分類
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
M P Goren et al.
The Pediatric infectious disease journal, 8(5), 278-282 (1989-05-01)
A three-drug antibiotic regimen including vancomycin and amikacin has been recommended as effective treatment in clinical settings in which Gram-positive bacteremias are a serious problem. To determine if vancomycin potentiates the tubular proteinuria associated with amikacin therapy, we studied febrile
H W Horowitz et al.
Antimicrobial agents and chemotherapy, 45(3), 786-788 (2001-02-22)
Human granulocytic ehrlichiosis is a recently described disease caused by an obligate intracellular gram-negative organism recently named Ehrlichia phagocytophila. To expand our knowledge of the susceptibility of E. phagocytophila, we tested six New York State isolates for susceptibility to 12
G J Alangaden et al.
Antimicrobial agents and chemotherapy, 42(5), 1295-1297 (1998-05-21)
An A1400G mutation of the rrs gene was identified in Mycobacterium tuberculosis (MTB) strain ATCC 35827 and in 13 MTB clinical isolates resistant to amikacin-kanamycin (MICs, >128 microg/ml). High-level cross-resistance may result from such a mutation since MTB has a